BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35006027)

  • 1. Cutaneous ulceration as a presenting feature of type 1 lepra reaction: A case report.
    Hegde P; Jaiswal D; Shetty VM; Pai K; Rao R
    Trop Doct; 2022 Apr; 52(2):354-356. PubMed ID: 35006027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localized and persistent erythema nodosum leprosum - a rare variant?
    Prabhu S; Rao R; Sripathi H; Rao L; Singh R
    Dermatol Online J; 2008 Mar; 14(3):16. PubMed ID: 18627717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histoid leprosy complicated by erythema nodosum leprosum mimicking connective tissue disease.
    Pal D
    Trop Doct; 2023 Oct; 53(4):533-535. PubMed ID: 37401254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lepromatous leprosy in Saudi female from central region.
    al-Majed S
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1940331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M; Berhe D
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bullous erythema nodosum leprosum manifesting in the post partum period with unusual features.
    Verma R; Vasudevan B; Pragasam V; Moorchung N; Mitra D; Gopal M
    Lepr Rev; 2015 Mar; 86(1):96-101. PubMed ID: 26065152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythema nodosum leprosum presenting as sweet's syndrome-like reaction in a borderline lepromatous leprosy patient.
    Suryawati N; Saputra H
    Int J Mycobacteriol; 2018; 7(2):191-194. PubMed ID: 29900900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of recurrent steroid-dependent severe type 2 lepra reaction treated successfully with colchicine.
    Sachdeva S; Sinha S; Sardana K
    Int J Mycobacteriol; 2021; 10(4):472-474. PubMed ID: 34916470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annular vesiculobullous eruptions in type 2 reaction in borderline lepromatous leprosy: a case report.
    Kar HK; Raina A; Sharma PK; Bhardwaj M
    Indian J Lepr; 2009; 81(4):205-8. PubMed ID: 20704077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual non-trophic ulcerations in leprosy: A case series of 17 patients.
    Shukla P; Malhotra KP; Verma P; Suvirya S; Saraswat A; Jain A
    Trop Doct; 2021 Oct; 51(4):542-552. PubMed ID: 33722150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
    Vijayakumaran P; Manimozhi N; Jesudasan K
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for erythema nodosum leprosum.
    Manandhar R; LeMaster JW; Roche PW
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifampicin-induced erythema nodosum leprosum-like eruption in borderline lepromatous leprosy.
    Karthikeyan K; Thappa DM; Kadhiravan T
    Indian J Lepr; 2001; 73(2):167-9. PubMed ID: 11579653
    [No Abstract]   [Full Text] [Related]  

  • 15. Reactive perforating leprosy, erythema multiforme-like reactions, sweet's syndrome-like reactions as atypical clinical manifestations of Type 2 leprosy reaction.
    Gunawan H; Yogya Y; Hafinah R; Marsella R; Ermawaty D; Suwarsa O
    Int J Mycobacteriol; 2018; 7(1):97-100. PubMed ID: 29516895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International workshop on erythema nodosum leprosum (ENL)--consensus report; the formation of ENLIST, the ENL international study group.
    Walker SL; Saunderson P; Kahawita IP; Lockwood DN
    Lepr Rev; 2012 Dec; 83(4):396-407. PubMed ID: 23614260
    [No Abstract]   [Full Text] [Related]  

  • 17. Case Report: Rapid Response to Low-Dose Thalidomide in a Case of Severe Steroid Recalcitrant Erythema Nodosum Leprosum.
    Savitha B; Sardana K; Kumari R; Khurana A; Sinha S; Sachdeva S
    Am J Trop Med Hyg; 2021 Oct; 106(1):51-53. PubMed ID: 34662871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare atypical presentations in Type 2 lepra reaction: a case series.
    Vijendran P; Verma R; Vasudevan B; Mitra D; Badad A; Neema S
    Int J Dermatol; 2014 Mar; 53(3):323-6. PubMed ID: 24134145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case Report: Necrotizing Erythema Nodosum as a Manifestation of Lepromatous Leprosy Relapse 50 Years after the Initial Infection.
    Galeano J; Contreras A; Pabón L; Ruiz AC; Serrano-Coll H; Arboleda M
    Am J Trop Med Hyg; 2023 Jul; 109(1):53-56. PubMed ID: 37253443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum.
    Schmitz V; Prata RB; Barbosa MG; Mendes MA; Brandão SS; Amadeu TP; Rodrigues LS; Ferreira H; Costa Fda M; Dos Santos JB; Pacheco Fdos S; Machado Ade M; Nery JA; Hacker Mde A; Sales AM; Pinheiro RO; Sarno EN
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004955. PubMed ID: 27556927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.